Evidence map›Paper›PMID 42290402›Full record

ArticleChembiochem : a European journal of chemical biology2026

Substrate Specificity of B12-Depedent Ribonucleotide Reductases: Biotechnology and Metabolic Implications.

Lobna Eltoukhy, Christoph Loderer

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lobna EltoukhyNucleotide Biotechnology Group, Chair of Molecular Biotechnology, Dresden, Germany.
Christoph LodererNucleotide Biotechnology Group, Chair of Molecular Biotechnology, Dresden, Germany.ORCID https://orcid.org/0000-0002-3795-8250

Funding

Deutsche Forschungsgemeinschaft INST269/780-1FUGGDeutsche Forschungsgemeinschaft LO2678/2-1
6 · The paper itself

Abstract

Ribonucleotide reductases (RNRs) catalyze one of the central biochemical reactions, giving rise to deoxyribonucleotides, the building blocks of DNA. Due to their importance in cellular metabolism, this class of enzymes has been extensively studied over five decades. One aspect that has been neglected so far is the substrate specificity in terms of noncanonical nucleotides. While some of these compounds are physiologically relevant, many non-natural nucleotides are important in medical science, biotechnology and synthetic biology. In this study, we investigated the substrate specificity of two thermostable RNRs for a broad range of natural and non-natural nucleotides, in order to define the substrate promiscuity of this class of enzymes. Both enzymes were capable of converting all canonical nucleotides and a variety of other nucleotides. Generally, the enzymes were more likely to convert substrates with modifications of already existing functional groups of the nucleobase core structure. Our results show the potential and limitations for the biotechnological application of RNRs. In addition, they improve our understanding of the natural nucleotide metabolism in dealing with naturally occurring nucleotide analogues.

Indexed as

BiotechnologyCobamidesRibonucleotide ReductasesNucleotidesSubstrate SpecificityCobamidesNucleotidesRibonucleotide Reductasesallosteric regulationbiocatalysisnon‐canonical nucleotidesnon‐natural nucleic acidsribonucleotide reductases

Identifiers

PMID42290402
PMCPMC13266583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.